Results 241 to 250 of about 79,832 (312)

Plasma-Derived von Willebrand Factor/Factor VIII Concentrate (Haemate P) in von Willebrand Disease: A Systematic Review and Pharmacovigilance Update. [PDF]

Haemophilia
Ettingshausen CE, Lassila R, Escolar G, Male C, Schirner K, Heyder L, Berntorp E.   +6 more
europepmc   +1 more source

Heavy Menstrual Bleeding and Hormonal Therapy in Women with Type 1 von Willebrand Disease Enrolled on the Zimmerman Program. [PDF]

Clin Appl Thromb Hemost
Machin N, Navarrete A, Rothenberger S, Flood V, Christopherson P, Montgomery R, Ragni MV, Zimmerman Program Investigators.   +7 more
europepmc   +1 more source

Application of genetic testing for the diagnosis of von Willebrand disease. [PDF]

J Thromb Haemost
Seidizadeh O, Baronciani L, Lillicrap D, Peyvandi F.   +3 more
europepmc   +1 more source

Safety and Efficacy of the Use of pdVWF/FVIII-C in Patients with von Willebrand Disease: A Prospective, Observational, Post-Authorization Study. [PDF]

Clin Appl Thromb Hemost
Benítez Hidalgo O, Marzo Alonso C, López Jaime FJ, Carrasco M, Nieto Hernández MDM, Afonso N, Lei A, Whyms D, Hanna K, Aragonés ME, Torres M, Oliveras J.   +11 more
europepmc   +1 more source

Single-domain antibodies for brain targeting [PDF]

, 2014
Lalatsa, Katerina, Moreira Leite, Diana
core   +1 more source

Adherence and Quality of Life in Adult Patients With Haemophilia A, Haemophilia B and Von Willebrand Disease: A National Cross-Sectional Survey. [PDF]

Eur J Haematol
Clausen CML, Funding E, Tolver A, Jarden M.   +3 more
europepmc   +1 more source

Efficacy of regular prophylaxis with a plasma-derived von Willebrand factor/factor VIII concentrate with a 1:1 activity ratio in reducing heavy menstrual bleeding in girls/women with von Willebrand disease. [PDF]

AJOG Glob Rep
Kiss C, Boda Z, Khayat CD, Boban A, Dubey L, Sidonio RF.   +5 more
europepmc   +1 more source

Efficacy and safety of plasma-derived von Willebrand factor/factor VIII concentrate (wilate) prophylaxis in children and adolescents with von Willebrand disease - WIL-31 study post hoc analysis. [PDF]

Res Pract Thromb Haemost
Sidonio RF, Dubey L, Vilchevska KV, Inati A, Djambas Khayat C.   +4 more
europepmc   +1 more source